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Abstract
Background: Glaucoma is a major blinding disease characterized by progressive loss of retinal ganglion cells (RGCs) and
axons. Optineurin is one of the candidate genes identified so far. A mutation of Glu
50 to Lys (E50K) has been reported to be
associated with a more progressive and severe disease. Optineurin, known to interact with Rab8, myosin VI and transferrin
receptor (TfR), was speculated to have a role in protein trafficking. Here we determined whether, and how optineurin
overexpression and E50K mutation affect the internalization of transferrin (Tf), widely used as a marker for receptor-
mediated endocytosis.
Methodology/Principal Findings: Human retinal pigment epithelial (RPE) and rat RGC5 cells transfected to overexpress wild
type optineurin were incubated with Texas Red-Tf to evaluate Tf uptake. Granular structures or dots referred to as foci
formed in perinuclear regions after transfection. An impairment of the Tf uptake was in addition observed in transfected
cells. Compared to overexpression of the wild type, E50K mutation yielded an increased foci formation and a more
pronounced defect in Tf uptake. Co-transfection with TfR, but not Rab8 or myosin VI, construct rescued the optineurin
inhibitory effect, suggesting that TfR was the factor involved in the trafficking phenotype. Forced expression of both wild
type and E50K optineurin rendered TfR to colocalize with the foci. Surface biotinylation experiments showed that the
surface level of TfR was also reduced, leading presumably to an impeded Tf uptake. A non-consequential Leu
157 to Ala
(L157A) mutation that displayed much reduced foci formation and TfR binding had normal TfR distribution, normal surface
TfR level and normal Tf internalization.
Conclusions/Significance: The present study demonstrates that overexpression of wild type optineurin results in
impairment of the Tf uptake in RPE and RGC5 cells. The phenotype is related to the optineurin interaction with TfR. Our
results further indicate that E50K induces more dramatic effects than the wild type optineurin, and is thus a gain-of-function
mutation. The defective protein trafficking may be one of the underlying bases why glaucoma pathology develops in
patients with E50K mutation.
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Introduction
Glaucoma, a major blinding disease worldwide [1], is character-
ized by progressive loss of retinal ganglion cells (RGCs) and axons,
as well as cupping of the optic nerve head. The most common form
of this disease, primary open angle glaucoma (POAG) is frequently
associated with elevated intraocular pressure (IOP) [2].
Recent genetic studies have demonstrated that POAG is highly
heterogeneous, caused by several susceptibility genes and perhaps
also environmental factors [1–5]. To date, three candidate genes,
myocilin, optineurin and WD40-repeat36, have been identified for
POAG. Among them, optineurin is a gene that links particularly to
normal pressure glaucoma, a subtype of POAG that accounts for
approximately 30% of the POAG cases [6]. In this condition, the
glaucomatous damage occurs with the intraocular pressures within
the normal limits, although the progression of the damage is
believed to be still IOP dependent [6]. Optineurin mutations were
noted to vary with ethnic background [7]. Mutations including
Glu
50RLys (E50K), Met
98RLys (M98K), and Arg
545RGln
(R545Q) in optineurin have been reported. The E50K mutation,
found in Caucasian and Hispanic populations [7], seems to be
associated with a more progressive and severe disease [8].
The human optineurin gene encodes a protein that contains
multiple coiled-coil domains, at least one leucine zipper (amino
acids 143–164) and a C-terminal zinc finger [9]. The optineurin
protein from different species has high amino acid homology and
the amino acid residue 50 glutamic acid is conserved [10].
Optineurin is ubiquitously expressed in non-ocular tissues such as
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trabecular meshwork (TM), retinal pigment epithelium (RPE)
[10], and non-pigmented ciliary epithelium [10,11]. RGCs are
immunolabeled with a high intensity [12].
Optineurin shares a 53% amino acid homology with NEMO
(NF-kB essential modulator) and was identified as a NEMO-
related protein [13]. Recently, optineurin has been shown to be a
negative regulator of NF-kB [14]. Like NEMO, the C-terminal
half of the optineurin sequence binds K-63 linked polyubiquiti-
nated chains [15–17].
Optineurin has also been demonstrated to interact with
transcription factor IIIA [18], Rab8 [12,19–22], huntingtin
[19], myosin VI [20,21], metabotropic glutamate receptor [23],
and TANK-binding kinase 1 [24]. In optineurin-overexpressing
human RPE and TM cells, granular structures or dots referred to
as foci that formed near the nucleus are noted to partially
colocalize with transferrin receptor (TfR) [25]. Rab8, hun-
tingtin, myosin VI, and TfR are all players in membrane traffic-
king [26–28], and optineurin has also been implicated in protein
trafficking [17,20,22].
Protein trafficking by the endocytic pathway is an essential
cellular mechanism critical for many functions including cell
signaling, nutrient acquisition and maintenance of the plasma
membrane [29]. The uptake route is composed of organelles,
known as endosomes that communicate in a unidirectional manner
from early to late endosomes to lysosomes. The best characterized
endocytic pathway is clathrin-dependent endocytosis that mediates
the constitutive uptake of ligands such as transferrin [30].
Previously, studies using small interfering RNA (siRNA) have
suggested that optineurin is involved in the exocytosis of vesicular-
stomatitis-virus G protein [20]. Here we undertook an investiga-
tion to determine in RPE cells and a model of RGC [31], RGC5
cell line [32], the effects of optineurin overexpression and
downregulation as well as E50K mutation on the internalization
of transferrin (Tf), which has been extensively used as a marker for
receptor-mediated endocytosis via clathrin-coated pits [33]. While
RGC is a cell type of direct relevance to glaucoma, RPE cells are
not currently implicated in any forms of glaucoma. They were
chosen for the study largely based on the finding that optineurin is
prominently expressed in the RPE tissue in mouse and monkey
eyes [10,34]. In both RPE and RGC5 cells, the possible
association between optineurin and markers of vesicular trafficking
compartments was assessed. In addition, biochemical interactions
between optineurin and various small GTPase Rab proteins,
active protagonists in the transport of macromolecules along the
endocytic pathways, and TfR, were determined by co-immuno-
precipitation (IP).
Results
Reduction of Tf uptake by expression of wild type
optineurin-green fluorescence protein (OPTNWT-GFP)
We previously reported that the optineurin foci formed upon
forced expression of OPTNWT-GFP in the perinuclear region,
colocalizing with a population of TfR, a marker for endosomal
vesicles [25]. To determine whether the overexpression affects Tf
uptake, human RPE cells transfected with pOPTNWT-GFP or
pEGFP-N1 (a plasmid vector used as a mock control here; genes
can be cloned into this vector to be expressed as fusions to the N-
terminus of GFP, for example, optineurin-GFP) were incubated
with Texas red-conjugated Tf (TR-Tf) at 37uC. After 15 min,
intense accumulation of red-fluorescent TR-Tf in perinuclear
areas were seen in nontransfected (non-green) and GFP mock-
transfected green cells (Fig. 1Aa and Ab). By comparison, the Tf
accumulation in OPTNWT-GFP-expressing cells (Fig. 1Ac and Ad)
was much reduced.
The Tf uptake in RPE cells was quantified. Six time points (0,
2, 5, 8, 10 and 15 min; Fig. 1B) were examined. The Tf uptake
in pEGFP-N1-transfected cells was similar to that in nontrans-
fected cells during the entire time course, indicating that GFP
mock transfection did not affect the Tf internalization kinetics.
On the other hand, the Tf uptake was significantly decreased
(P,0.0001) in pOPTNWT-GFP-transfected cells. The reduction
of Tf uptake was observed from the initial 2- and 5-min time
points (Fig. 1B). For comparison purposes, RPE and TM cells
were transfected to overexpress wild type myocilin-GFP [35]
and its influence on Tf uptake was investigated. Unlike
optineurin, myocilin did not exhibit any effect on the kinetics
of Tf internalization (Fig. 1C, data shown were from TM cells).
The inhibition of Tf uptake upon transfection with pOPTNWT-
GFP in RPE cells was likewise observed in RGC5 cells (Figs. 1D
and 1E).
Lack of association between optineurin foci and
endocytic markers on the Tf uptake route
The TfR-Tf complex is internalized through clathrin-coated
pits, transported to peripheral early/sorting endosomes and then
recycled back to cell surface either directly or via the pericentriolar
recycling endosomes. RPE cells were transfected with pOPTNWT-
GFP and immunostained for endosomal marker protein (Fig. 2A)
or co-transfected with pTarget-FLAG-OPTNWT and pGFP-Rabs
to co-express endocytic markers (Fig. 2B). The molecules
investigated included EEA1 (early endosome antigen-1) (Fig. 2A),
an early endosome marker, Rab5 (Fig. 2B), a protein that controls
the initial transport of Tf to early endosomes, Rab4, a marker
found in both early and recycling endosomes, and Rab7, a marker
for late endosomes. Results showed that there was no major
colocalization with any of these marker proteins (Figs. 2A and B,
Rab4 and Rab7 data not shown).
Co-IP was subsequently performed. RPE cells co-transfected
with pTarget-FLAG-OPTN and pEGFP-N1, pGFP-Rab8,
pGFP-Rab4, pGFP-Rab5, pGFP-Rab11 or pGFP-Rab7 were
lysed and immunoprecipitated with anti-optineurin. Plasmids
pEGFP-N1 and pGFP-Rab8 were included as a negative and
a positive control, respectively. The resulting precipitates were
subjected to immunoblotting. An anti-FLAG antibody detected
the 75-kDa FLAG-optineurin band in all IP products (Fig. 2C,
lanes 1–6), verifying that IP was properly performed. When anti-
GFP antibody was used, only GFP-Rab8 band was obtained
(Fig. 2C, lane 2), indicating that optineurin co-precipitated with
GFP-Rab8 but not with any other Rabs. It was not due to poor
expression of GFP-Rabs, because anti-GFP detected a fairly high
amount of GFP or GFP-Rab proteins in total cell lysates (Fig. 2C,
lanes 7–12). This suggested that optineurin had minimal
association with proteins such as Rab5 that have active roles in
Tf endocytosis.
Rescue of Tf uptake by co-transfection with TfR but not
with myosin VI and Rab8 constructs
To determine whether the impairment of Tf uptake could be
rescued by optineurin binding proteins myosin VI, Rab8, or
TfR, RPE (Fig. 3) and RGC5 (data not shown) cells were co-
transfected with pOPTNWT-GFP along with pMyoVI-EGFP,
pRab8Q67L-EGFP, or pTfR-EGFP [36] for 16 h. They were
then incubated with TR-Tf and the Tf uptake was quantified.
It was found that co-transfection with myosin VI and Rab8
constructs (Fig. 3A) had little effect, while co-expression of TfR
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PLoS ONE | www.plosone.org 2 July 2010 | Volume 5 | Issue 7 | e11547expression plasmid (Fig. 3A) restored the Tf uptake to the
nontransfected control level in OPTNWT-GFP-expressing
cells (Fig. 3B). The yellow staining in perinuclear regions
(Fig. 3A, bottom panel, merged) indicated interaction and
colocalization between the expressed TfR-GFP and the
internalized TR-Tf.
Figure 1. Overexpression of optineurin-GFP (OPTNWT-GFP) but not myocilin-GFP (MYOC-GFP) impedes transferrin (Tf) uptake. (A)
Fluorescent images of GFP (Aa and Ab)- and OPTNWT-GFP (Ac and Ad)-expressing RPE cells after incubation with Texas red-Tf (TR-Tf) for 15 min. The
cells were fixed and the fluorescent images were captured under a Leica confocal microscope. Transfected cells (green) are seen in Aa and Ac and the
internalized TR-Tf (red) is seen in Ab and Ad. Scale bar, 20 mm. (B) Quantification of TR-Tf uptake in GFP (green filled circles)-, and OPTNWT-GFP (pink
squares)-expressing RPE cells. Fluorescence intensity of TR-Tf in the cells was measured at 0-, 2-, 5-, 8-, 10-, and 15-min time points. Images in seven
randomly selected 206 fields, each containing at least 8 transfected cells, were analyzed. TR-Tf internalization for samples at each time point is
expressed as percentage relative to that of the 15-min uptake in GFP-expressing mock control cells. Data presented are mean 6 standard deviation
(SD) from a representative of three independent experiments. *, P,0.0001 (n=8) compared to GFP controls. (C) Quantification of TR-Tf uptake in GFP
(green filled circles)-, or MYOC-GFP (blue diamonds)-expressing TM cells. (D) Fluorescent images of GFP (Da and Db)- and OPTNWT-GFP (Dc and Dd)-
expressing RGC5 cells (green) after incubation with TR-Tf (red, Db and Dd) for 15 min. Scale bar, 20 mm. (E) Quantification of TR-Tf uptake in GFP
(green filled circles)-, and OPTNWT-GFP (pink squares)-expressing RGC5 cells. Fluorescence intensity of TR-Tf in the cells was measured at the 0-, 8-,
and 15-min time points. The uptake is expressed as percentage (mean 6 SD) relative to that of the 15-min uptake in GFP-expressing control cells.
Experiments were repeated at least three times with similar results. *, P,0.001 compared to GFP controls.
doi:10.1371/journal.pone.0011547.g001
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by OPTNWT-GFP expression
The TfR protein level in pEGFP-N1 (mock control)- or
pOPTNWT-GFP-transfected RPE cells was examined by Western
blotting. The glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
levelwasusedasaproteinloadingcontrol.Inaddition,thelevelofthe
endogenous optineurin and the OPTNWT-GFP fusion protein was
also determined to confirm that the cells were indeed transfected.
Results in Fig. 4A showed that the TfR level in cells expressing
OPTNWT-GFP was similar to that of the mock control. The
reduction of Tf uptake in pOPTNWT-GFP-transfected cells was thus
unrelated to the expression level of total TfR.
In GFP-expressing as well as nontransfected cells, punctate TfR
staining was seen distributing largely diffusely in the cytoplasm
(Fig. 4Bb). After optineurin transfection, TfR was observed to
become more concentrated in the perinuclear region, colocalizing
at least partially with the optineurin foci (Fig. 4Be and f). It
appeared that TfR was recruited and sequestered in the
perinuclear area by the optineurin foci.
Tf uptake, total TfR level and TfR distribution in cells
expressing OPTNE50K-GFP
We have shown that overexpression of a disease-causing mutant
optineurin, OPTNE50K, induced foci formation more prominently
than that seen in the wild type [25]. Here, experiments were
carried out to evaluate whether E50K expression affects the Tf
uptake. As seen in Fig. 5A, the TR-Tf accumulation within 15 min
in OPTNE50K-GFP-expressing cells was much reduced compared
to that in the neighboring nontransfected and GFP control (data
not shown) cells. Quantitative analyses (Fig. 5B) showed that the
Figure 2. Lack of interactions between wild type optineurin (OPTNWT) and endocytic markers on the Tf uptake route. (A) RPE cells
transfected to express OPTNWT-GFP (Aa, green) were immunostained with anti-EEA1 (Ab, red). (B) RPE cells co-transfected with pTarget-FLAG-OPTNWT
and pGFP-Rab5WT (Ba, green) for 16 h were immunostained with anti-FLAG antibody (Bb, red). Merged images are presented in Ac and Bc. Optineurin
foci largely did not colocalize with EEA1 (A) or Rab5 (B). Scale bar, 20 mm. (C) Co-immunoprecipitation (IP) of optineurin with Rab proteins. RPE cells
expressing FLAG-OPTNWT along with GFP (lanes 1 and 7), GFP-Rab8 (lanes 2 and 8), GFP-Rab4 (lanes 3 and 9), GFP-Rab5 (lanes 4 and 10), GFP-Rab11
(lanes 5 and 11), or GFP-Rab7 (lanes 6 and 12) were immunoprecipitated with anti-optineurin. The resulting IP eluates (lanes 1–6) were
immunoblotted (IB). The 75-kDa FLAG-OPTN and 50–52-kDa GFP-Rabs were detected by anti-FLAG and anti-GFP antibodies, respectively. Thirty
micrograms of cell lysates (lanes 7–12) were analyzed with the same antibodies to evaluate the expression level of fusion proteins.
doi:10.1371/journal.pone.0011547.g002
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PLoS ONE | www.plosone.org 4 July 2010 | Volume 5 | Issue 7 | e11547Figure 3. Rescue of Tf uptake by co-transfection with TfR but not with myosin VI and Rab8 constructs in RPE cells. (A) Fluorescent
images of RPE cells. The cells transfected with pOPTNWT-GFP (OPTN) alone, or co-transfected with pOPTNWT-GFP and pMyoVI-EGFP (OPTN + HM6),
pRab8Q67L-EGFP (OPTN + Rab8), or pTfR-EGFP (OPTN + TfR) were incubated with Texas Red-Tf (TR-Tf) for 15 min. The single or co-transfected cells are
in green and the internalized TR-Tf is seen in red. The yellow staining in perinuclear regions (bottom panel, merged) indicated interaction and
colocalization between the expressed TfR-GFP and the internalized TR-Tf. Scale bar, 20 mm. (B) Quantification of TR-Tf uptake in nontransfected and
single- or co-transfected RPE cells. Note that co-transfection with myosin VI and Rab8 constructs had little effect, while co-expression of TfR restored
the Tf uptake to the nontransfected control level in OPTNWT-GFP-expressing cells. Data are expressed as mean 6 SD. Experiments are repeated at
least three times, yielding similar results. *, P,0.001 compared to nontransfected cells.
doi:10.1371/journal.pone.0011547.g003
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reduction was more pronounced in cells expressing OPTNE50K-
GFP (approximately 70–80% reduction) than OPTNWT-GFP
(approximately 30–40% reduction, Fig. 1B).
Forced expression of OPTNE50K-GFP, similar to that seen with
the wild type (Figs. 4A and 4B), did not alter the total level of TfR
(Fig. 5C), but changed the TfR localization to a more perinuclear
pattern (Fig. 5D). An enhanced colocalization between the
OPTNE50K foci and TfR was observed (Fig. 5D).
Tf uptake, total TfR level and TfR distribution in cells
expressing OPTNL157A-GFP
Leucine zipper motif is known to be sites for protein-protein
interactions. Optineurin protein contains one leucine zipper
domain (amino acid residues 143–164) at the N-terminus and
Rab8 has been suggested to interact with optineurin through the
N-terminal region (amino acid residues 141–209) that includes the
leucine zipper domain [12,19–22,37]. To obliterate this domain,
we introduced a point mutation by in vitro mutagenesis to
substitute Leu
157 to Ala (L157A) in the optineurin sequence.
OPTNL157A construct in pEGFP vector (pOPTNL157A-GFP) was
made. When transfected, two patterns of OPTNL157A-GFP
distribution were noted in human RPE (Fig. 6A), TM (Fig. 6C),
and RGC5 (data not shown) cells. In about 60–70% of transfected
cells, foci formation was hardly seen and the OPTNL157A-GFP
fusion protein distributed diffusely throughout the cytoplasm
(Fig. 6Aa and 6Ca). Foci were observed in the remaining cells but
they were not concentrated in the perinuclear area (Fig. 6Ab and
6Cb). Compared to those seen in wild type optineurin-expressing
cells, the OPTNL157A foci appeared to be fewer in number, smaller
Figure 4. Effects of optineurin overexpression on the total level and distribution of the endogenous TfR in RPE cells. (A )Lysates
(50 mg total protein) from cells transfected with pEGFP-N1 (lane 1) or pOPTNWT-GFP (lane 2) were immunoblotted with anti-TfR (Aa), anti-optineurin
(OPTN) (Ab), and anti-GAPDH (Ac) antibodies. The expression level of 95-kDa TfR was not reduced by OPTNWT-GFP overexpression. Anti-OPTN
detected the 74-kDa endogenous OPTN band in both lanes and a 100-kDa OPTNWT-GFP band in lane 2. Anti-GAPDH that detected a 37-kDa band,
was used to control protein loading. (B) Distribution of TfR in GFP- and OPTNWT-GFP-expressing cells. RPE cells transfected with pEGFP-N1 (Ba-Bc,
green) and pOPTNWT-GFP (Bd-Bf, green) were immunostained with anti-TfR (Bb, Bc, Be, Bf, red). Merged images are shown in Bc and Bf. Colocalization
between OPTNWT-GFP and TfR is seen in yellow (Bf).
doi:10.1371/journal.pone.0011547.g004
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counting confirmed the microscopic observations that cells
transfected with pOPTNL157A-GFP had on average a lower
number of foci compared with those transfected with pOPTNWT-
GFP (10.3611 versus 50.3 61,9 in RPE cells, P,0.0001, Fig. 6B;
11.562.3 versus 64.662.1 in TM cells, P,0.0001, Fig. 6D).
OPTNL157A-GFP-Expressing RPE cells were incubated with
TR-Tf to assess the Tf uptake. As shown in Fig. 6E, the
fluorescence intensity of TR-Tf after a 15-min uptake was similar
in cells expressing OPTNL157A-GFP and nontransfected cells.
Quantitative analyses verified that the Tf uptake was unaltered by
the L157A mutation compared to GFP controls (Fig. 6F).
Furthermore, overexpression of OPTNL157A-GFP did not vary
the total level (Fig. 6G), nor the largely diffuse cytoplasmic
distribution pattern (Fig. 6H) of TfR.
Self binding of optineurin mutants and interactions with
Rab8 and TfR
Our laboratory has previously reported that wild type
optineurin interacts with itself to form homo-hexamer as well as
with its binding partners to form supermolecular complexes [36].
The foci formation is presumably related to these complex
formations. To determine whether a point mutation of optineurin
at amino acid residue 50 from Glu to Lys or residue 157 from Leu
to Ala would change its ability to self interact, RPE cells were co-
transfected with pOPTNE50K-His + pTarget-FLAG-OPTNE50K
and pOPTNL157A-His + pTarget-FLAG-OPTNL157A for 16 h.
Cells were also co-transfected with pOPTNWT-His + pTarget-
FLAG-OPTNWT as a positive control. The lysates were
immunoprecipitated with a polyclonal anti-His antibody and the
IP eluates were immunoblotted with a monoclonal anti-FLAG
antibody (Fig. 7A, top panel). The anticipated molecular weight of
the proteins detected by anti-FLAG antibody was 75 kDa. The
membrane was also immunoblotted with anti-His monoclonal
antibody to verify that IP was properly performed (Fig. 7A, lower
panel). The results revealed that both E50K and L157A mutants
were still capable of binding to themselves and the binding was
comparable to that of the wild type optineurin. Native blue gel
electrophoresis performed further detected formation of the
420 kDa homo-hexamer by the wild type and the two optineurin
mutants (data not shown).
Rab8 has been suggested to bind to optineurin through the
leucine zipper-containing N-terminal region [12,19–22,37]. To
determine whether E50K or L157A mutation affects the Rab8
binding, tetracycline-regulated (Tet-on) inducible stable RGC5
cell lines [36] established in our laboratory were used. These cells,
treated with doxycycline for 16 h to induce the expression of
E50K-, L157A-, as well as wild type optineurin-GFP [36], offered
an advantage that the expression of fusion protein was essentially
uniform in culture plates. The level of induced gene expression
Figure 5. Effects of OPTNE50K-GFP expression on Tf uptake, total TfR level, and TfR distribution in RPE cells. (A) Fluorescent images of
RPE cells transfected with pOPTNE50K-GFP for 16 h and incubated with TR-Tf for 15 min. The transfected cells are in green (Aa) and the internalized
TR-Tf is seen in red (Ab). Scale bar, 20 mm. (B) Quantification of TR-Tf uptake in GFP (green filled circles)- and OPTNE50K-GFP (red triangles)-expressing
cells. Fluorescence intensity of TR-Tf in the cells was measured at various time points. *, P,0.0001 compared to GFP controls. (C) Lysates (50 mg total
protein) from RPE cells transfected with pEGFP-N1 (lane 1) or pOPTNE50K-GFP (lane 2) were immunoblotted with anti-TfR (Ca), anti-optineurin (OPTN)
(Cb), and anti-GAPDH (Cc) antibodies. The expression level of 95-kDa TfR was similar in lanes 1 and 2. A 74-kDa endogenous optineurin band and a
100-kDa OPTNE50K-GFP band were detected. The GAPDH level was used to control protein loading. (D) RPE cells transfected with pOPTNE50K-GFP (Da,
green) were immunostained with anti-TfR (Db, red). Merged image (Dc) shows colocalization between OPTNE50K-GFP and TfR in yellow.
doi:10.1371/journal.pone.0011547.g005
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PLoS ONE | www.plosone.org 7 July 2010 | Volume 5 | Issue 7 | e11547Figure 6. Cellular localization of OPTNL157A-GFP and effects of OPTNL157A-GFP expression on Tf uptake, total TfR level, and TfR
distribution. (A) RPE cells were transfected with pEGFP-N1 (GFP mock control, not shown), pOPTNL157A-GFP (a and b) or pOPTNWT-GFP (c) for 16 h.
Representative confocal images shown in Aa and Ab depict two major patterns of OPTNL157A distribution. Scale bar, 20 mm. (B) The number of foci in
at least 60 RPE transfectants was counted and the average number of foci per transfectant is shown. Data (mean 6 SD) presented are representative
from three independent experiments. *, P,0.0001 compared to OPTNWT-GFP-expressing cells. (C) Human TM cells were transfected pEGFP-N1 (mock
control, not shown), pOPTNL157A-GFP (a and b) or pOPTNWT-GFP (c). Two patterns of OPTNL157A distribution are seen in a and b. Scale bar, 20 mm. (D)
The number of foci in TM transfectants was counted. The average number of foci per transfectant (mean 6 SD) is presented. *, P,0.0001 compared
to OPTNWT-GFP-expressing cells. (E) Fluorescent images of OPTNL157A-GFP-expressing RPE cells after internalization of TR-Tf for 15 min. The
transfected cells are in green (Ea) and the internalized TR-Tf is shown in red (Eb). Scale bar, 20 mm. (F) Quantification of TR-Tf uptake in OPTNL157A-
transfected RPE cells. Fluorescence intensity of TR-Tf, determined as in Fig. 1B, is expressed as percentage relative to that of the 15-min uptake in
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the endogenous level, as in our experiments) from selected clones.
By contrast, cell transfection, depending on transfection efficiency,
generally yielded only a population of transfected cells, compli-
cating quantitative assessments. The level of transgene expression
was also difficult to regulate.
Co-IP was performed using anti-GFP antibody and the
precipitated proteins were probed with anti-Rab8 to detect the
pull down of the endogenous Rab8 (Fig. 7B, upper panel). Anti-
GFP probing was also used to verify the IP procedure and to
determine the expression level of GFP fusion proteins (Fig. 7B,
lower panel). Results obtained disclosed that the 27-kDa Rab8 was
present in all three pull downs. The level of Rab8 immunopre-
cipitated by anti-GFP from the lysate of OPTNE50K-GFP-
expressing cells was approximately 5 fold higher than that from
OPTNWT-GFP-expressing cells, indicating a stronger Rab8
binding by the E50K mutant. The Rab8 binding however was
reduced by approximately 5 fold by the L157A mutation. These
data suggested that the leucine zipper domain in optineurin is at
least partially required for Rab8 binding.
The inducible RGC5 cell lines were similarly used to provide
quantitative assessment of the TfR binding capability of wild type
and mutant optineurin. Cell lysates were immunoprecipitated with
polyclonal anti-GFP, and the IP eluates were immunoblotted with
mouse anti-TfR to detect the endogenous TfR. Again, the E50K
mutant bound approximately 10-fold higher, while the L157A one
bound roughly 5-fold lower, amounts of endogenous TfR than the
wild type optineurin (Fig. 7C, top panel). The same membrane
was also immunoblotted with anti-GFP (Fig. 7C, lower panel).
Level of TfR on the cell surface
To provide further evidence that the sequestration of TfR by
the optineurin foci may be an important factor in blocking of the
Tf uptake, the level of surface TfR was determined. The surface
proteins in transfected RPE cells were labeled with non-permeable
sulfo-NHS-SS-biotin reagent as described previously [38]. Results
(Fig. 8) showed that relative to a well-known surface protein, b1-
integrin, the surface TfR level in OPTNWT-GFP and OPTNE50K-
GFP overexpressing cells was markedly decreased than that in
GFP controls. Transfection with pOPTNL157A-GFP, on the other
hand, did not lower the TfR level on the cell surface.
Optineurin knock down by siRNA compromises the Tf
uptake
Scrambled (mock control) or optineurin siRNA was transfected
into RPE cells for 2 days. These cells were then incubated with
TR-Tf. Fluorescent microscopy showed that the amount of Tf
internalized after 15 min in optineurin-depleted cells was
considerably lower than that in mock controls (Fig. 9A). The
fluorescence intensity, measured at 5 different time points (2, 5, 8,
10 and 15 min), was significantly (P,0.045 for the 2-min time
point, P,0.0001 for others) reduced in cells transfected with
optineurin siRNA (Fig. 9B). The TR-Tf intensity in optineurin
siRNA-treated cells was generally about 50–65% of that in
scrambled controls. The expression level of optineurin was, as
anticipated, downregulated in optineurin siRNA-transfected cells
compared to controls (Fig. 9C), while the total TfR expression
level was unchanged (Fig. 9C). Intracellular distribution of TfR
was also similar in both scrambled and optineurin siRNA-treated
cells (Fig. 9D).
Discussion
Optineurin is a gene linked to glaucoma. The present study
demonstrates that overexpression of wild type optineurin results in
an impairment of the Tf uptake in both RPE and RGC5 cells
(Fig. 1). Such a phenotype, interestingly, was not observed when
the cells were transfected to overexpress myocilin, product of
another glaucoma gene (Fig. 1C). These new findings support our
previous conclusions [32,35] that the two glaucoma genes have
different functions and may contribute to the development of
glaucoma via distinct mechanisms.
The uptake defect manifested by optineurin overexpression can
be rectified by co-expression of TfR, but not by myosin VI or
Rab8 (Fig. 3), all of which are optineurin-interacting proteins
[17,19,25,36,37]. The new data suggest that TfR, but not myosin
VI or Rab8, may be the key factor involved in the optineurin
inhibitory phenotype. The total level of TfR is found maintained
after optineurin transfection (Fig. 4A). However, TfR molecules
that distribute diffusely in the cytoplasm are seen to become
concentrated around the perinuclear region, colocalizing at least
partially with the foci in transfected cells (Fig. 4B). More
remarkably, the surface TfR level is substantially decreased
(Fig. 8). It appears therefore that the TfR molecules, via
interactions with optineurin, are recruited and sequestered by
the foci formed near the perinuclear area (Fig. 7B). This arrest
consequently leads to diminished availability of surface TfR and
an impeded Tf uptake.
E50K is a mutation prevalent in patients with normal tension
glaucoma [6,8]. Our data, consistent with those published very
recently [17], revealed that the E50K mutation, with an enhanced
ability to interact with TfR (Fig. 7B), blocked the Tf uptake
(Fig. 5A and 5B), modified the TfR distribution (Fig. 5D), and
depleted the surface TfR (Fig. 8) even more dramatically than the
wild type. This, along with the previous observations of a more
prominent foci formation, more severe fragmentation of the Golgi
complex [25], and a higher level of apoptosis [32] than the wild
type, strongly indicates that E50K is a gain-of-function mutation.
The PROSITE analysis [39] suggests that introduction of
Glu
50RLys mutation results in no particular changes either in
the structure or the conformation of optineurin (data not shown).
Nevertheless, patients who have E50K mutation in clinical setting
are reported to suffer glaucomatous defects more severe than those
without this mutation [8].
L157A mutation has not been identified clinically in any
patients to date and is more than likely not disease causing or
related. Opposing to the E50K mutation, few foci were formed in
cells expressing OPTNL157A-GFP (Fig. 6A–D) and the forced
expression had no discernible effects on the Tf uptake (Fig. 6E and
6F). Perhaps due to the much decreased interaction with TfR
(Fig. 7B), the TfR distribution (Fig. 6H) and the cell surface TfR
level (Fig. 8) was unaffected by the L157A mutation. Taken all the
data together, we conclude that the inhibition of Tf uptake
triggered by overexpressed wild type and E50K optineurin is
related to the interaction between optineurin and TfR, the
GFP-expressing controls. Data (mean 6 SD) presented are representative of three independent experiments. (G) Lysates (50 mg total protein) from
RPE cells transfected with pEGFP-N1 (lane 1) or pOPTNL157A-GFP (lane 2) were immunoblotted with anti-TfR (Ga), anti-optineurin (OPTN) (Gb), and
anti-GAPDH (Gc, used to control protein loading) antibodies. Total level of the 95-kDa TfR was similar in lanes 1 and 2. A 74-kDa endogenous
optineurin band and a 100-kDa OPTNL157A-GFP band were detected. (H) RPE cells transfected with pOPTNL157A-GFP (Ha, green) were immunostained
with anti-TfR (Hb, red). The diffuse distribution of OPTNL157A-GFP overlapped with that of TfR in yellow in the merged image (Hc).
doi:10.1371/journal.pone.0011547.g006
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the ensued attenuation of TfR molecules on the cell surface.
By computer analysis (http://2zip.molgen.mpg.de/), the change
of Leu
157 to Ala in the optineurin sequence may lead to
obliteration of the leucine zipper (data not shown). The much
reduced ability of L157A mutant to interact with Rab8 (Fig. 7B)
and TfR (Fig. 7C) suggests that the optineurin association with
Rab8 and TfR requires, at least in part, an intact leucine zipper
motif. Since the ubiquitin binding domain (UBD) and the myosin
VI and hungtintin interaction sites all reside in proximity to the C-
terminus of the optineurin sequence [16,17], neither the
ubiquitination nor the aforementioned protein interactions should
be impacted by the E50K or the L157A mutation. In support of
this notion, both mutants, like the wild type optineurin, were
found to be ubiquitinated (data not shown).
The foci formed in wild type and E50K optineurin-expressing
cells are likely due to self binding of both the wild type and E50K
molecules as well as their interactions with other proteins including
Rab8 and TfR. Leucine zipper motif is known to be sites for
protein-protein interactions. Since the L157A optineurin is still
capable of interacting with itself (Fig. 7A), the lack of foci
formation in L157A optineurin-GFP-expressing cells, in compar-
ison to the wild type and the E50K counterparts, may be related to
the perturbed binding of this mutant to Rab8 (Fig. 7B) and TfR
(Fig. 7C) and perhaps other as-yet-unknown leucine zipper-
binding protein(s) as well.
As stated above, our finding that E50K mutation results in a
reduced uptake of Tf has been reported recently by Nagabhush-
ana et al. [17]. Other consequences of E50K mutation [25,36,
present study] such as the formation of foci (vesicular structures)
and enhanced binding with Rab8 and TfR are also consistent with
those descried previously [17]. The Tf uptake phenotype was not
observed by Nagabhushana et al. [17] when the wild type
optineurin was force expressed in HeLa cells, whereas it was seen
in our hands using RPE and RGC5 cells. The disparity could be
related to differences in cell types. Our study in addition provided
quantitative data and biochemical evidence to substantiate the
notion that the declined Tf uptake is related to the attenuated TfR
level on the cell surface (Fig. 8).
Nagabhushana et al. in their report suggested that the UBD of
optineurin is required for the formation of vesicular structures
(foci), impairment of Tf uptake, and cell death [17]. Yet the
current L157A findings indicate that the leucine zipper motif is
also a requirement. As discussed above, the UBD located in the C-
terminal region is intact in the L157A mutant, which was found
ubiquitinated (data not shown). This mutant, similar to the
Figure 7. Self binding of optineurin mutants and their
interactions with Rab8 and TfR. (A) Self binding of wild type
optineurin and mutants. RPE cells were co-transfected with pOPTNWT-
His + pTarget-FLAG-OPTNWT, pOPTNE50K-His + pTarget-FLAG-OPTNE50K,
or pOPTNL157A-His + pTarget-FLAG-OPTNL157A for 16 h. Cell lysates were
immunoprecipitated (IP) with polyclonal anti-His. The IP eluates were
immunoblotted (IB) with monoclonal anti-FLAG or monoclonal anti-His.
The anticipated molecular weight of the proteins detected by both
antibodies was 75 kDa. No protein band was detected when rabbit IgG
was used for immunoprecipitation (data not shown). (B) Binding of wild
type optineurin and mutants with endogenous Rab8. Inducible RGC5
cells were treated with doxycycline for 16 h to express OPTNWT-GFP,
OPTNE50K-GFP and OPTNL157A-GFP. Cell lysates were immunoprecipitat-
ed (IP) with polyclonal anti-GFP. The IP eluates were immunoblotted (IB)
with monoclonal anti-Rab8 or polyclonal anti-GFP. The intensity ratio
between the detected 27-kDa-Rab8 band and the 100 kDa-OPTN-GFP
band relative to that of the wild type optineurin is presented. No
protein band was observed in lysate samples obtained from non-
induced cells (data not shown). (C) Binding of wild type optineurin and
mutants with endogenous TfR. Inducible stable cell lines were induced
by doxycycline to express OPTNWT-GFP, OPTNE50K-GFP or OPTNL157A-
GFP. Cell lysates were immunoprecipitated (IP) with a polyclonal anti-
GFP antibody. The IP eluates were immunoblotted (IB) with a
monoclonal anti-TfR antibody or anti-GFP. The intensity ratio between
the 95-kDa TfR band and the 100 kDa-OPTN-GFP band relative to that
of the wild type optineurin is presented. No protein band was observed
in lysate samples obtained from non-induced cells (data not shown).
doi:10.1371/journal.pone.0011547.g007
Figure 8. Overexpression of wild type and E50K optineurin, but
not L157A mutant, alters the surface TfR level in RPE cells. Cells
were transfected to express GFP, as well as wild type (WT)-, E50K-, and
L157A-optineurin-GFP. Surface TfR was detected by Western blotting
with anti-TfR after surface protein biotinylation and isolation of
biotinylated proteins. The level of surface TfR was normalized to that
of a well known cell surface protein, b1-integrin. The ratios of TfR to b1-
integrin are presented. Ctl, nontransfected control RPE cells.
doi:10.1371/journal.pone.0011547.g008
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mutant [17], does not cause much foci formation (Fig. 6A–D) or
induce apoptosis (data not shown) as was seen in the wild type and
E50K optineurin cases. This argues for the conclusion that both
the UBD at the C-terminus and the leucine zipper motif at the N-
terminus are necessary requirements for the foci formation, Tf
trafficking phenotype and apoptosis.
Using siRNA techniques, a previous study [10] showed that
downregulation of optineurin reduced significantly the transport of
vesicular-stomatitis-virus G protein to the cell surface [20] and
altered the morphology of Golgi complex in normal rat kidney and
HeLa cells. We have extended the investigation, demonstrating
that knocking down optineurin compromised the Tf uptake. In
addition, we showed that the optineurin depletion did not alter
either the total TfR level or its distribution in cells.
As both the overexpression and the suppression of optineurin
cause a reduction in the Tf internalization, a role of optineurin in
this process is implicated. In the literature, there have been reports
of various genes [40–45] displaying identical or similar phenotypes
under both overexpression and depletion conditions. For example,
inhibition of Tf internalization was seen to result from both
overexpression and siRNA-mediated silencing of EHD2 (EH
domain protein 2) [40]. Genes Rab22a [41], REP15 (Rab15
effector protein) [42], and Hrs (hepatocyte growth factor-regulated
tyrosine kinase substrate) [43,44] have also been noted to generate
the same phenotype upon overexpression and knockdown:
inhibited Tf recycling, inhibited TfR recycling, and impaired
degradation of epidermal growth factor, respectively. In the
budding yeast, overexpression and deletion of Bud2 both resulted
in a significance increase in the rate of actomyosin ring contraction
[45]. In this last example, Bud2 overexpression was thought to act
as a dominant negative. In the others, it was speculated that
overexpression may lead to formation of unbalanced protein
complexes, trapping proteins associated with endocytosis steps and
inhibiting in turn their normal functions. This appears to be the
likely scenario involved in optineurin overexpression. Evidence is
Figure 9. Knockdown of the endogenous optineurin inhibits Tf uptake but has little effect on the TfR level or distribution in RPE
cells. (A) Fluorescence images of RPE cells transfected for 48 h with 50 nM generic scrambled control or optineurin (OPTN) siRNA after a 15-min
uptake of TR-Tf (in red). Scale bar, 20 mm. (B) Quantification of Tf uptake in scrambled (dark gray filled circles)- and OPTN siRNA-(orange squares)
transfected cells. Fluorescence intensity of 7 randomly selected 206fields at 0-, 2-, 5-, 8-, 10-, and 15-min time points was measured and divided by
the number of cells. The internalized TR-Tf at each time point was expressed as percentage relative to that of the 15-min uptake in scrambled siRNA-
transfected cells. Data (mean 6 SD) presented are representative of three independent experiments. *, P,0.0001 compared to scrambled controls.
(C) Expression level of endogenous TfR and optineurin in optineurin siRNA-treated cells. The cell lysates were immunoblotted with anti-TfR, anti-
optineurin (OPTN), and anti-GAPDH. The TfR level was not altered while the optineurin knockdown (lane 2) was confirmed. Anti-GAPDH antibody was
used to assess protein loading. (D) RPE cells were transfected with scrambled or OPTN siRNA along with Cy3-labeled control siRNA. Cy3 (red)
fluorescence was seen in nearly all cells (top panel), indicating that the siRNA transfection efficiency was .95%. These cells were immunostained with
anti-TfR (green, bottom panel) for TfR distribution. No alteration was observed. Scale bar, 20 mm.
doi:10.1371/journal.pone.0011547.g009
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overexpressed optineurin is mediated largely through the foci
formation and the augmented optineurin-TfR interaction. The
precise mechanism involved in the depletion situation however still
remains to be defined.
E50K produces a more prominent foci formation [17,25], more
severe fragmentation of the Golgi complex [25], and a higher level of
apoptosis [32] than overexpression of the wild type optineurin.
Representing a gain-of-function mutation, E50K acts also via similar
mechanisms as the wild type overexpression to more dramatically
impair the Tf trafficking. A growing number of mutations in
trafficking proteins have been linked with neurodegenerative diseases
[46,47] and glaucoma is also recognized as a neurodegenerative
disorder. Based on our current and previous [25] findings,we surmise
that the defective trafficking, along with fragmentation of the Golgi
complex [48] and increased apoptosis [49,50], may be the underlying
basis how the E50K optineurin mutation renders the patients
predisposed to the glaucoma pathology. Correction or restoration to
the normal trafficking process by TfR may be a strategy that merits
exploration and further investigation.
It is further of note that while the E50K finding has pathologic
significance, the wild type optineurin overexpression results are
also of physiologic relevance. Optineurin, for example, has been
shown to be upregulated by proinflammatory cytokines tumor
necrosis factor-a (TNF-a) [13,51] and interferon [13]. Its
expression therefore may be heightened to set off adverse
consequences upon chronic inflammation and infection. Increases
of TNF-a in the retina and the optic nerve head have also been
associated with glaucomatous conditions [52].
Materials and Methods
Cell Cultures and transfection
The RPE cell line ARPE-19 obtained from American Type
Culture Collection (Masnassas, VA) and RGC5 cells [32] were
grown in complete medium containing Dulbecco’s modified
Eagle’s medium (DMEM; Invitrogen, Carlsbad, CA), 10% fetal
bovine serum, essential and nonessential amino acids, and
antibiotics. Normal human TM tissues excised from eyes of
donors (Illinois Eye Bank, Chicago, IL) 24, 38, and 47 years of age
were cultured on Falcon Primaria flasks in complete medium
[25,35]. When cells reached confluence, they were trypsinized and
subcultured.
Transient transfection was carried out using FuGENE6 (for
RPE and TM cells, Roche, Indianapolis, IN) or lipofectamine
LTX and Plus reagent (for RGC5 cells, Invitrogen) as previously
described [25,32,36].
Tet-on OPTNWT-GFP inducible stable RGC5 cell line was
established as previously described [35]. Tet-on inducible
OPTNE50K-GFP and OPTNL157A-GFP RGC5 cell lines were in
addition created following the same procedures and strategies. The
only exception was that the OPTNWT-GFP fragment was replaced
with OPTNE50K-GFP or OPTNL157A-GFP fragment during the
first cloning step [36]. The cells were maintained in DMEM
complete medium with 10% Tet system certified fetal bovine
serum (Invitrogen), essential and nonessential amino acids, and
antibiotics. To induce expression of OPTNWT-GFP, OPTNE50K-
GFP, and OPTNL157A-GFP, cells were treated for 16 h with
doxycycline (1 mg/ml) (Clontech, Mountain View, CA) in DMEM
complete medium.
Plasmid construction
Plasmids pOPTNWT-GFP, pOPTNE50K-GFP, pTarget-FLAG-
OPTNWT,p T a r g e t - F L A G - O P T N E50K, pMyocilin-GFP, pRab8Q67L-
EGFP, and pTfR-EGFP were constructed as previously described
[25,32,35,36]. Human myosin VI full length fused to EGFP (pMyoVI-
EGFP) was generously provided by Dr. Tama Hasson, University of
California San Diego. Plasmid pOPTNL157A-GFP was generated by
QuikChange II Site-Directed Mutagenesis Kit (Stratagene, La Jolla,
CA). The sense primer sequence used for mutagenesis was 59-
CAGAGAAGGCAGACGCGTTGGGCATCGTGTC-39.T h ea n -
tisense primer sequence was the reverse. To generate open reading
frame of Rab5, Rab7, Rab8 and Rab11, cDNAs were synthesized
from total RNA of RPE cells by Superscript II cDNA synthesis kit
(Invitrogen). Rab4 cDNA was obtained from University of Missouri-
Rolla cDNA resource center (Rolla, MO). The cDNAs were used as
templates for PCR amplification with primers: 59-GGCGAATTC-
TATGTCGCAGACGGCCATGTC-39 and 59-GGCGGATCCC-
TAACAACCACACTCCTGAGCG-39for Rab4; 59- GGCGAATT-
CTATGGCTAGTCGAGGCGCAAC-39 and 59-GGCGGATCC-
TTAGTTACTACAACACTGATTCCTGG-39for Rab5; 59- GGC-
GAATTCTATGACCTCTAGGAAGAAAGTG-39 and 59-GGCG-
GATCCTCAGCAACTGCAGCTTTCTG-39 for Rab7; 59- GGC-
GAATTCTATGGCGAAGACCTACGATTA-39 and 59- GGCG-
GATCCTCACAGAAGAACACATCGGA-39 for Rab8; 59- GGC-
GAATTCTATGGGCACCCGCGACGACGA-39 and 59- GGCG-
GATCCTTAGATGTTCTGACAGCACTGCACC-39 for Rab11.
The resulting PCR products were digested with EcoRIa n dBamHIa n d
cloned in frame into pEGFP-C1 (BD Biosciences, San Jose, CA) at the
s a m er e s t r i c t i o ns i t e st oy i e l dc o n s t r u c t sp G F P - R a b 4 ,- R a b 5 ,- R a b 7 ,-
Rab8 and -Rab11. Plasmids pOPTNWT-His, pOPTNE50K-His and
pOPTNL157A-His were made by adding a His tag to the C-terminal of
optineurin by PCR using pOPTNWT-GFP, pOPTNE50K-GFP or
pOPTNL157A-GFP as the template and the subsequent subcloning of
OPTNWT-His, OPTNE50K-His or OPTNL157A-His into EcoR V
linearized pcDNA3.1z vector (Clontech). Sequencing was followed to
verify all the constructs.
Antibodies
The following antibodies were used: rabbit polyclonal anti-
optineurin (Cayman Chemical, Ann Arbor, MI), anti-GFP (Santa
Cruz Biotechnology, Santa Cruz, CA), anti-GAPDH (Trevigen,
Gaithersburg, MD), anti-His (Santa Cruz), and anti-b1-integrin
(GIBCO-BRL, Grand Island, NY), and mouse monoclonal anti-
human TfR (Zymed Laboratories, San Francisco, CA), anti-FLAG
(Sigma, St. Louis, MO), anti-EEA1 (BD Biosciences), anti-myosin
VI (sigma), anti-Rab8 (BD Biosciences), anti-His (Sigma) and anti-
GFP (BD Biosciences).
Tf uptake and quantification
Cells grown on glass chamber slides were washed in phosphate-
buffered saline (PBS) and incubated in DMEM containing 0.2%
bovine serum albumin (BSA) (DMEM-BSA) for 1 h to deplete
serum. The cells were transferred to fresh DMEM-BSA containing
25 mg/ml TR-Tf (Invitrogen) and incubated for the indicated time
periods. The cells were then placed on ice, washed with cold PBS
containing 0.2% BSA, 1 mM CaCl2 and 1 mM MgCl2, incubated
with cold acid buffer (0.2 M acetic acid, 0.5 M NaCl) and ice-cold
PBS, fixed, and mounted in Vectashield with DAPI (Vector
Laboratories, Burlingame, CA). Photography was carried out on a
Leica SP2 confocal system (Leica Microsystems, Bannockburn, IL)
with a 636oil objective using sequential scanning to minimize the
bleed through. Confocal images were captured using the same
resolution, zoom, pinhole size, and amplitude offset. All cells were
captured at the same gain. TR-Tf internalization at each time
point was quantified as previously described [53]. In brief, using
the Leica confocal software, the average grayscale pixel intensity
was measured in a small region without any staining. This value
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was set to this value. Since the transfection efficiency of plasmid
construct was relatively low in contrast to high efficiency of siRNA
transfection (.95%), two different methods were applied to
measure internalized TR-Tf intensity. For cells transfected with
GFP constructs, the outline of single cells was drawn and the
fluorescence intensity was measured from inside of the cell. The
resulting red intensity at each time point was averaged from cells
in seven 206 fields in which at least 8 untransfected and 8
transfected cells were selected. For siRNA transfected cells, seven
206fields, each containing 30–50 transfected cells, were chosen.
The total red intensity was acquired and normalized to the
number of cells in each field. Three sets of independent
experiments were carried out. The significance of the data was
determined by Students’ t tests.
Immunoblotting
Cells were washed with ice-cold PBS and harvested in
CelLytic
TM-M cell lysis reagent (Sigma) containing protease
inhibitor cocktail (Complete; Roche, Indianapolis, IN). The lysates
were centrifuged at 12,0006 g for 10 min at 4uC. Protein
concentration in lysates was determined using the bicinchoninic
acid (BCA) assay (Pierce, Rockford, IL) per the manufacturer’s
protocol. Aliquots of total cell lysate were separated on sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
and electroblotted onto Protran BA83 nitrocellulose membrane
(Whatman, Sanford, ME). After blocking for 1 h with 5% nonfat
dry milk in a buffer containing 20 mM Tris buffer (pH 7.4),
150 mM NaCl and 0.1% Tween 20, the membrane was incubated
with primary antibody for 1 h at room temperature or overnight
at 4uC. The blot was further incubated for 1 h with horseradish
peroxidase-conjugated secondary antibody (1:10,000; Jackson
ImmunoResearch Laboratories, West Grove, PA). Protein bands
were detected using SuperSignal Substrate (Pierce). For repeated
probing, the blot was stripped for 1 h at room temperature with
ImmunoPure IgG Elution buffer (Pierce).
Immunofluorescence microscopy
Cells (18,000 cells/well) on Lab-Tek 8-well CC2 glass chamber
slides (Nalge Nunc, Rochester, NY) were transfected and fixed
with 4% paraformaldehyde in PBS for 15 min. After permeabi-
lization in 0.2% Triton X-100 for 5 min, the cells were blocked
with 3% BSA for 30 min, and incubated with primary antibody in
blocking solution for 1 h at room temperature. They were further
incubated for 45 min with Cy3- or FITC-conjugated secondary
antibody (1:200; Jackson ImmunoResearch Laboratories), and
mounted. Confocal images were captured.
Co-IP using transient transfection or inducible cell lines
Cells plated on 6-well plates were transfected with indicated
plasmids for 16 h. For inducible cell lines, the cells were treated
with 1 mg/ml of doxycycline for 16 h. After washes with ice-cold
PBS, the cells were harvested in IP buffer (50 mM Tris-HCl,
pH 7.5, 150 mM NaCl, 1% Nonidet P40, 0.5% sodium
deoxycholate, protease inhibitor cocktail) and homogenized by
ten strokes in a pre-chilled dounce homogenizer on ice. The
homogenates were clarified by centrifugation at 12,0006 g for
10 min at 4uC. Protein concentration in homogenates was
determined by BCA assay. Aliquots of the homogenates were
subjected to immunoblotting or IP reaction using Catch and
Release v2.0 kit (Millipore, Billerica, MA) according to manufac-
turer’s protocol with minor modifications. Briefly, 500 mg of the
homogenates were incubated overnight with 4 mg of indicated
rabbit polyclonal antibodies and 10 ml of Antibody Capture
Affinity Ligand (Millipore) on a rotary shaker with gentle shaking
at 4uC. The mixture was transferred to a spin column containing
agarose resin slurry and further incubated for 30 min on a rotary
shaker at room temperature. Columns were washed three times
with 16 wash buffer (Millipore). Protein was eluted with 16
denaturing elution buffer (Millipore). The eluates were subjected
to SDS-PAGE and immunoblotting.
siRNA-mediated knock down of optineurin
RPE cells were plated in complete media at 80 to 90%
confluency overnight. The cells were transfected with 50 nM of
siRNA duplex (Dharmacon, Lafayette, CO) for 2 days using
TransIT-TKO transfection reagent (Mirus Bio Corporation,
Madison, WI) according to the manufacturer’s protocol. Target
sequence of optineurin siRNA was 59-GAAGCCATGAAGC-
TAAATA-39 and matched to 166–184 bp of ORF. As a control, a
19-nucleotide scrambled generic control siRNA (Dharmacon) was
used. In some experiments, cells were transfected with scrambled
or optineurin siRNA along with Cy3-labeled control siRNA
(Dharmacon) to assess transfection efficiency.
Optineurin foci counting
RPE and TM cells were transfected with pEGFP-N1,
pOPTNWT-GFP or pOPTNL157A-GFP for 16 h. Images were
taken using a 636oil objective. The number of foci formed was
counted in at least 60 transfected cells both manually and through
the use of Metamorph software. The significance of the data was
determined by Students’ t tests. Three sets of independent
experiments were analyzed.
Biotinylation of cell surface proteins
Surface biotinylation was performed as described [53,54] with
modifications. Briefly, RPE cells after transfection for 16 h were
washed with ice-cold PBS. They were then incubated for 20 min
at 4uC in a 1 ml solution containing the non-permeable Sulfo-
NHS-SS-Biotin reagent (1 mg/ml in PBS). The cells were washed
with PBS plus 100 mM lysine for 20 min to quench the reagent.
After additional washes, the cells were lysed with lysis buffer for
30 min. The biotinylated proteins were recovered by incubating
the lysate for 2 h at room temperature with streptavidin–agarose
beads. After washes of the beads, the protein bound to the beads
was separated by SDS/PAGE and immunoblotted with anti-TfR
for the biotinylated surface TfR. As a control, the biotinylated b1-
integrin, a cell surface protein, was probed with anti-b1-integrin.
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